CardiologyTier 2Topic

The incidence of, and the risk factors for, cardiovascular disease in individuals and patient groups - elderly patients

Overview

Cardiovascular disease incidence rises steeply with age, and both risk assessment and management require age-specific adaptation - standard risk calculators and treatment thresholds derived from middle-aged populations do not translate directly to the very elderly
Cardiovascular disease is the leading cause of death in older adults; by very advanced age, age itself becomes the dominant risk factor, often outweighing the incremental contribution of other modifiable factors captured in standard risk scores

Age-related arterial stiffening (reduced elastin, increased collagen/calcification) raises systolic BP and pulse pressure, itself an independent cardiovascular risk factor distinct from mean BP
Atypical presentation is common - silent MI, presentation with confusion/falls/generalised deterioration rather than classic chest pain, particularly with frailty or cognitive impairment

Standard risk calculators lose discriminative value at very advanced age (most very elderly patients are "high risk" by any calculator) - clinical judgement, frailty assessment, and patient goals of care become more important than the calculated percentage

Balance absolute risk reduction against competing risks, polypharmacy burden, and patient priorities - a treatment with strong trial evidence in middle-aged populations may offer less net benefit (or net harm) in a frail 90-year-old with limited life expectancy
Statin and antihypertensive therapy generally still provide benefit into older age in relatively fit older adults, but deprescribing is increasingly considered in frailty/limited prognosis, given the time-to-benefit for primary prevention often exceeds remaining life expectancy
Orthostatic hypotension risk rises with age and with antihypertensive intensity - a key safety consideration (falls risk) distinct from younger patients

Shared decision-making, incorporating the patient's goals and expected benefit/harm balance over their remaining life expectancy, is central to cardiovascular risk management in advanced age - a guideline-directed target is a starting point, not an automatic mandate, in this population

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.